To further determine the correlation between serum levels of HSP90 beta in HNSCC and their response to HT treatment, the HNSCC patients were categorized as CR or NR at the end of chemo-radiation therapy (CRT)+HT treatment session. Here, HSP90AB1 is linked to head and neck squamous cell carcinoma.